Skip to main content

Study Reveals new Danger from E-Cigarette Flavorings

Electronic cigarettes, commonly known as e-cigs or vapes are a new and developing technology, yet little is known about the medical risk they pose to users. A new study offers insight into the effects of e-cigs. The flavoring used in nicotine juices may pose a risk to blood vessels and the cells within the heart.
Although e-cigarettes were originally marketed as a cleaner alternative to smoking or a tool to help smokers quit, “They have also gained popularity among young people. According to the Centers for Disease Control and Prevention (CDC), there was an increase in middle and high school students using e-cigarettes from 2011 to 2016.”
Ultimately, the study concluded that, “Our work and prior research have provided evidence that flavorings induce toxicity in the lung and cardiovascular systems. Flavorings are also a driver of youth tobacco use and sustained tobacco use among smokers."
Due to the cardiovascular damage that e-cigs cause, it is recommended that medical professionals are prepared to treat patients affected by them properly; thus, it is advised that ACLS and BCLS courses are taken. Advanced cardiac life support and basic cardiac life support are staples of proper cardiovascular treatment. These credentials may be earned online through skills testing. Websites like offer online modules, free practice tests, and free study materials. This best prepares clients to succeed in their ACLS online and BCLS online testing.
As e-cigarettes gain popularity, many more will be negatively affected, including young people. Therefore, PALS or pediatric advanced life support is another practical credential to complete. E-cigarettes are not going away, so it is clear that medical professionals must be prepared to treat their side effects.


Popular posts from this blog

PALS Study Materials -Normal Pediatric Vital Signs

Stop Taking That Aspirin You Were Told To Take

Taking a low-dose aspirin every day to prevent a heart attack or stroke is no longer recommended for most older adults, according to guidelines released Sunday.  After doctors said for decades that a daily 75 to 100 milligrams of aspirin could prevent cardiovascular problems, the American College of Cardiology and the American Heart Association reversed that idea.  A large clinical trial found a daily low-dose aspirin had no effect on prolonging life in healthy, elderly people and actually suggested the pills could be linked to major hemorrhages.
Sunday's recommendations say low-dose aspirin should not be given to prevent atherosclerotic cardiovascular disease on a routine basis to adults older than 70 or any adult at an increased risk of bleeding.  “Clinicians should be very selective in prescribing aspirin for people without known cardiovascular disease,” cardiologist Roger Blumenthal said in a statement. "It’s much more important to optimize lifestyle habits and control bl…